(i)
|
proxy statement with respect to the Company’s annual general meeting of
shareholders (the “Meeting”) to be held at 4:00 p.m. (Israel time) on June 26, 2024, at the Company’s offices at 9 Hapsagot St., Park Ofer B, Petach-Tikva, Israel, describing proposals to be voted upon at the Meeting, the procedure for voting in person or by proxy at the
Meeting and various other details related to the Meeting; and
|
(ii)
|
a proxy card for use in connection with the Meeting.
|
|
CYBERARK SOFTWARE LTD.
|
|
|
|
|
|
|
Date: May 22, 2024
|
By:
|
/s/ Donna Rahav
|
|
|
|
Name: Donna Rahav
|
|
|
|
Title: Chief Legal Officer
|
|
Exhibit
|
|
Description
|
|
|
|
|
||
|
|
o |
Annual Recurring Revenue, or ARR,(1) reached $774 million as of December 31, 2023, increasing 36% year‑over‑year.
|
|
o |
Subscription portion of ARR(1) reached $582 million as of December 31, 2023, increasing 60% year‑over‑year.
|
|
o |
Total revenue of $752 million in 2023, growing 27% year-over-year and accelerating from the 18% revenue growth in 2022 compared to 2021.
|
|
o |
Non-GAAP operating income(1) of $33.5 million, a significant improvement from a non-GAAP loss of $22.4 million in 2022.
|
|
o |
During 2023, the Company’s net cash provided by operating activities was $56.2 million.
|
(1) |
See Appendix A for the definitions of Annual Recurring Revenue, Subscription Portion of Annual Recurring Revenue and non-GAAP operating income (loss), as well as a reconciliation of non-GAAP operating income to GAAP operating income
|
|
Ehud (Udi) Mokady |
|
|
|
Founder & Executive Chairman of the Board |
|
(1) |
To re‑elect each of Matthew Cohen and François Auque, and to elect Mary Yang, each for a term of approximately three years as a Class I director of the Company, until the Company’s annual general meeting of shareholders to be held in 2027
and until his or her respective successor is duly elected and qualified;
|
|
(2) |
To approve, in accordance with the requirements of the Israeli Companies Law, 5759-1999, a grant of performance share units and restricted share units for 2024 to the Company’s Executive Chairman of the Board, Ehud (Udi) Mokady;
|
|
(3) |
To approve amendments to the form of indemnification agreement for certain office holders of the Company;
|
|
(4) |
To approve certain amendments to the Articles of Association of the Company; and
|
|
(5) |
To approve the re‑appointment of Kost Forer Gabbay & Kasierer, registered public accounting firm, a member firm of Ernst & Young Global, as the Company’s independent registered public accounting firm for the year ending December 31,
2024, and until the Company’s 2025 annual general meeting of shareholders, and to authorize the Board of Directors of the Company (the “Board”) to fix such accounting firm’s annual compensation.
|
|
Sincerely, |
|
|
|
Ehud (Udi) Mokady |
|
Founder & Executive Chairman of the Board |
Agenda Items (Proposals)
|
Board Recommendation
|
Further Details
|
|
1. |
To re‑elect each of Matthew Cohen and François Auque, and to elect Mary Yang, each for a term of approximately three years as a Class I
director of the Company, until the Company’s annual general meeting of shareholders to be held in 2027 and until his or her respective successor is duly elected and qualified;
|
✔ FOR each of the
director nominees
|
Pages 18 to 19
|
2. |
To approve, in accordance with the requirements of the Israeli Companies Law, 5759-1999 (the “Companies
Law”), a grant of performance share units (“PSUs”) and restricted share units (“RSUs”) for 2024 to the Company’s Executive Chairman of the Board (“Executive Chair”), Ehud (Udi) Mokady;
|
✔ FOR
|
Pages 20 to 22
|
3. |
To approve amendments to the form of indemnification agreement for certain office holders of the Company;
|
✔ FOR
|
Pages 23 to 24
|
4. |
To approve certain amendments to the Articles of Association of the Company (the “Articles”);
and
|
✔ FOR
|
Pages 25 to 26
|
5. |
To approve the re‑appointment of Kost Forer Gabbay & Kasierer, registered public accounting firm, a member firm of Ernst &
Young Global, as the Company’s independent registered public accounting firm for the year ending December 31, 2024, and until the Company’s 2025 annual general meeting of shareholders, and to authorize the Board to fix such accounting firm’s
annual compensation.
|
✔ FOR
|
Pages 27 to 28
|
|
• |
By mail—If you are a shareholder of record, you can submit a proxy by completing, dating, signing and returning your proxy card in the postage‑paid envelope provided. You should
sign your name exactly as it appears on the enclosed proxy card. If you are signing in a representative capacity (for example, as a guardian, executor, trustee, custodian, attorney or officer of a corporation), please indicate your name and
title or capacity. If you hold shares in “street name,” you have the right to direct your brokerage firm, bank or other similar organization on how to vote your shares, and the brokerage firm, bank or other similar organization is required to
vote your shares in accordance with your instructions. To provide instructions to your brokerage firm, bank or other similar organization by mail, please complete, date, sign and return your voting instruction form in the postage‑paid envelope
provided by your brokerage firm, bank or other similar organization;
|
|
• |
By telephone—If you are a shareholder of record, you can submit a proxy by telephone by calling the toll‑free number listed on the enclosed proxy card, entering your control number
located on the enclosed proxy card and following the prompts. If you hold shares in “street name,” and if the brokerage firm, bank or other similar organization that holds your shares offers telephone voting, you may follow the instructions
shown on the enclosed voting instruction form in order to submit a proxy by telephone; or
|
|
• |
By Internet—If you are a shareholder of record, you can submit a proxy over the Internet by logging on to the website listed on the enclosed proxy card, entering your control number
located on the enclosed proxy card and submitting a proxy by following the on‑screen prompts. If you hold shares in “street name,” and if the brokerage firm, bank or another similar nominee that holds your shares offers Internet voting, you
may follow the instructions shown on the enclosed voting instruction form in order to submit your proxy over the Internet.
|
|
• |
providing leadership to the Board if circumstances arise in which the role of the Executive Chair may be, or may be perceived to be, in conflict with the interests of the Company, and responding to any reported conflicts of interest, or
potential conflicts of interest, arising for any director;
|
|
• |
presiding as chairman of meetings of the Board at which the Executive Chair is not present, including executive sessions of the independent members of the Board;
|
|
• |
serving as a liaison between the CEO and the independent members of the Board;
|
|
• |
providing feedback on Board meeting agendas, information and ongoing training provided to the Board, and requiring changes to the same;
|
|
• |
approving meeting schedules to ensure that there is sufficient time for discussion of all agenda items;
|
|
• |
having the authority to call meetings of the independent members of the Board;
|
|
• |
being available for consultation and direct communication with shareholders, as appropriate;
|
|
• |
recommending that the Board retain consultants or advisers that report directly to the Board;
|
|
• |
conferring with the Executive Chair or CEO on important Board matters and key issues and tasks facing the Company, and ensuring the Board focuses on the same;
|
|
• |
presiding over the Board’s annual self‑assessment process and the independent directors’ evaluation of the effectiveness of the Executive Chair, CEO and management; and
|
|
• |
performing such other duties as the Board may from time to time delegate to assist the Board in the fulfillment of its duties.
|
✔ Separated the Executive Chair and CEO roles
✔ Lead Director with expansive duties and extensive oversight experience
✔ 7 of 9 directors are independent
✔ Fully independent Audit, Compensation and Nominating and ESG Committees
✔ Ongoing board refreshment and succession planning ‑
✔ Board refreshment program with a commitment to add a new board member at least every five years – new
directors appointed in 2019, 2021 and 2023
✔ Thoughtful committee rotations – in 2022, appointed Mr. Auque and Ms. England to the Audit and Strategy
Committees, respectively, and in 2024 appointed Ms. England to the Nominating and ESG Committee
|
✔ Ongoing shareholder engagement program
✔ Annual Board and committee evaluations
✔ Executive sessions of Independent Directors
✔ Executive sessions with the Independent Auditors and key employees related to risk management
✔ Annual review of committee charters
✔ Regular internal audits of management responsibilities
✔ Board continuing education program
✔ Independent directors and committees’ direct communication with executive team and key employees
✔ In‑house team led by Head of Internal Audit who reports to Audit Committee
|
Committee
|
Risk Oversight Areas of Focus
|
Audit
|
• Our overall risk assessment and strategy for managing enterprise risk
|
• Accounting and financial reporting, legal, compliance and privacy
|
|
• Cybersecurity, including product and information security
|
|
Compensation
|
• Compensation policies and practices related to our directors, CEO, executives and employees
|
• Our human capital management and diversity, equity and inclusion strategy
|
|
Nominating and ESG
|
• ESG program, including corporate governance and environmental stewardship
|
Strategy
|
• Our long‑term business and corporate strategy, including organic and inorganic growth
|
BUSINESS EXPERTISE
|
CONSIDERATIONS
INDUSTRY EXPERIENCE |
DIVERSITY
|
o Corporate governance
o Financial
o Go‑to‑market strategy
o Product management
o Leadership
o M&A
o Risk management
o Strategy
o Sustainability
o Public Company
|
o Alliances and partnerships
o B2B
o Cloud
o Competitive analysis
o Cybersecurity
o Public sector
o SaaS or Software
o Information Technology
|
o Cultural background
o Ethnicity
o Gender identity
o Race
o Sexual orientation
o Experience
|
Country of Principal Executive Offices: | Israel |
Foreign Private Issuer: | Yes |
Disclosure Prohibited under Home Country Law: | No |
Total Number of Directors: | 9 |
Female
|
Male
|
Non-Binary
|
Did not Disclose Gender
|
|
Part I: Gender Identity
|
||||
Directors
|
3
|
6
|
‑‑
|
‑‑
|
Part II: Demographic Background
|
||||
Underrepresented Individual in Home Country Jurisdiction
|
--
|
|||
LGBTQ+
|
‑‑
|
|||
Did Not Disclose Demographic Background
|
1
|
✔ |
Compensation program is designed to incentivize superior individual excellence and link the compensation of our office holders to the Company’s success and, as a result, to align the interests of our office holders with those of our
shareholders
|
✔ |
Compensation that balances performance targets and time horizons to support the achievement of our financial, strategic and long‑term objectives, while remaining in line with market practices and the principles of our ESG program
|
✔ |
Annual review of our compensation program to ensure its compliance with applicable laws and regulations, market practices, as well as the Company’s targets and strategy
|
✔ |
Fully independent Compensation Committee, composed of at least three members
|
✔ |
Independent, outside consultant support in the design and analysis of our compensation program and advice regarding our executive and non‑employee director compensation
|
✔ |
Annual equity‑based compensation cap for both our executives and Board members
|
✔ |
Annual cash bonus payments cap for our executives
|
✔ |
Continuously enhancing our compensation practices to include a significant performance‑based component in our executives’ compensation. Currently, at least 50% of our executives’ annual equity grant is subject to performance‑based criteria
|
✔ |
Carefully managing and reducing our equity dilution level (currently below 10%)
|
✔ |
Prohibiting any transaction in the Company’s shares and derivatives that are speculative or short‑term in nature, create an actual or perceived conflict of interest, or bet against the Company’s future performance or short‑term prospects
|
✔ |
Recoupment provisions clawback policy for both cash and equity compensation in compliance with new SEC and Nasdaq requirements.
|
Targets
|
Performance Criteria Achievement Rate (Weighted Average)
|
Earning Rate
|
||
2020
|
•
•
•
|
Annual revenue
Non-GAAP profitability
License-derived revenue
|
80.0%
|
60.0%
|
2021
|
•
•
|
Annual recurring revenue
Percentage of new license subscription bookings out of total new license bookings, on an annualized basis
|
111.0%
|
183.0%
|
2022
|
•
•
|
Annual recurring revenue
Total new license bookings, on an annualized basis
|
99.0%
|
102.0%
|
2023
|
•
•
|
Annual recurring revenue
Operating Margin
|
181.3%
|
159.0%
|
Year of Grant
|
Percentile
|
Earning Rate
|
2020
|
49.7%
|
99.4%
|
2021
|
89.7%
|
200.0%
|
Alteryx, Inc.
|
Five9, Inc.
|
New Relic, Inc.
|
Tenable Holdings, Inc.
|
AppFolio, Inc.
|
GitLab Inc.
|
Okta, Inc.
|
Varonis Systems, Inc.
|
Box, Inc.
|
Guidewire Software, Inc.
|
Q2 Holdings, Inc.
|
Wix.com Ltd.
|
Cloudflare, Inc.
|
HashiCorp, Inc.
|
Qualys, Inc.
|
Zscaler, Inc.
|
CrowdStrike Holdings, Inc.
|
HubSpot, Inc.
|
Rapid7, Inc.
|
|
Dynatrace, Inc.
|
monday.com Ltd.
|
SentinelOne, Inc.
|
Lead Director
|
Member
|
|
Board
|
US$52,500
|
US$35,000
|
Committee
|
Chairperson
|
Member
|
Audit
|
US$20,000
|
US$10,000
|
Compensation
|
US$12,000
|
US$6,000
|
Nominating and ESG
|
US$8,000
|
US$4,000
|
Strategy
|
US$8,000
|
US$4,000
|
New Appointment Award
|
Up to US$350,000
|
Subsequent Annual Award
|
US$200,000
|
|
(1) |
our Class I directors are Matthew Cohen, François Auque and Mary Yang, whose current terms expire at the Meeting and upon the election and qualification of their respective successors,
|
|
(2) |
our Class II directors are Gadi Tirosh, Amnon Shoshani and Avril England, whose current terms expire at our 2025 annual general meeting of shareholders and upon the election and qualification of their respective successors, and
|
|
(3) |
our Class III directors are Ehud (Udi) Mokady, Ron Gutler and Kim Perdikou, whose current terms expire at our 2026 annual general meeting of shareholders and upon the election and qualification of their respective successors.
|
|
(a) |
“RESOLVED, that the re‑election of Matthew Cohen as a Class I director of the Company, for a term of approximately three years that expires at the third annual general meeting of shareholders to be
held following his re‑election, and until the due election and qualification of his successor, be, and hereby is, approved in all respects.”
|
|
(b) |
“RESOLVED, that the re‑election of François Auque as a Class I director of the Company, for a term of approximately three years that expires at the third annual general meeting of shareholders to be
held following his re‑election, and until the due election and qualification of his successor, be, and hereby is, approved in all respects.”
|
|
(c) |
“RESOLVED, that the election of Mary Yang as a Class I director of the Company, for a term of approximately three years that expires at the third annual general meeting of shareholders to be held
following her election, and until the due election and qualification of her successor, be, and hereby is, approved in all respects.”
|
RSUs
|
Business PSUs
|
Relative TSR PSUs
|
|
Percentage
|
50%
|
30%
|
20%
|
Amount
|
12,000
|
7,200
|
4,800
|
Approximate Value
|
$2,500,000
|
$1,500,000
|
$1,000,000
|
Percentile
|
Achievement Rate
|
|
Threshold
|
25th
|
50%
|
Target
|
50th
|
100%
|
Overachievement
|
75th
|
200%
|
|
• |
RSUs. Will vest over a four-year period. 25% of the RSUs will vest on February 15, 2025, with the remainder vesting on a quarterly basis thereafter, and becoming fully vested on February 15, 2028.
|
|
• |
Business PSUs. Will vest over a four-year period. Subject to the achievement of the relevant performance criteria, 25% of the earned Business PSUs will vest on February 15, 2025, with the remainder vesting on a quarterly basis
thereafter, and becoming fully vested on February 15, 2028.
|
|
• |
Relative TSR PSUs. Will vest following a three-year period. Subject to the achievement of the relevant performance criteria, earned Relative TSR PSUs will fully vest on February 15, 2027.
|
Subject
|
Proposed Amendments to Indemnification Agreement
|
Rationale
|
||
Insurance
|
•
|
Incorporate an obligation to maintain insurance policy and clarify the process for handling claims |
•
|
Align with previous proposal concerning the Company’s liability insurance coverage approved by shareholders in 2017
|
• | Increase procedural clarity and efficiency | |||
Indemnifiable Events
|
•
|
Broaden terminology beyond Israeli law requirements
|
•
|
Align with market practice for Israeli companies listed in the U.S.
|
•
|
Clarify language regarding applicability for certain type of events
|
• |
Address growing focus of enforcement measures and litigation
|
|
•
|
Add language regarding cybersecurity incidents and “distributions” (as defined under the Companies Law) to
shareholders |
• |
Align with the nature of the Company’s business and operations
|
|
Indemnification Amount
|
•
|
Indemnifiable Amount to apply to all indemnifiable persons, in aggregate, during a five-year period
|
•
|
Appropriately reflect the market standard for public Israeli companies of our size listed in the U.S. |
• |
Include additional criteria directly linking the Indemnification Amount cap to the Company’s market capitalization
|
|
(a) |
Any Shareholder or Shareholders of the Company holding at least the required percentage under the Companies Law of the voting rights
of the Company, which entitles such Shareholder(s) to require the Company to include a matter on the agenda of a General Meeting (the “Proposing Shareholder(s)”)
may request, subject to the Companies Law, that the Board of Directors include a matter on the agenda of a General Meeting to be held in the future, provided that the Board determines that the matter is appropriate to be considered in a
General Meeting (a “Proposal Request”). In order for the Board of Directors to consider a Proposal Request and whether to include the matter stated therein in the agenda of a General Meeting, notice
of the Proposal Request must be timely delivered in accordance with applicable laws, and the Proposal Request must comply with the requirement of these Articles (including this Article 25) and any applicable law and stock exchange rules and
regulations. The Proposal Request must be in writing, signed by all of the Proposing Shareholder(s) making such request, delivered, either in person or by certified mail, postage prepaid, and received by the Secretary (or, in the absence
thereof by the Chief Executive Officer of the Company). To be considered timely, a Proposal Request must be received within the time periods prescribed by applicable law. The announcement of an adjournment or postponement of a General
Meeting shall not commence a new time period (or extend any time period) for the delivery of a Proposal Request as described above. In addition to any information required to be included in accordance with applicable law, the Proposal
Request must include the following: (i) the name, address, telephone number, fax number and email address of the Proposing Shareholder (or each Proposing Shareholder, as the case may be) and, if an entity, the name(s) of the person(s) that
controls or manages such entity; (ii) the number of Shares held by the Proposing Shareholder(s), directly or indirectly (and, if any of such Shares are held indirectly, an explanation of how they are held and by whom), which shall be in
such number no less than as is required to qualify as a Proposing Shareholder, accompanied by evidence satisfactory to the Company of the record holding of such Shares by the Proposing Shareholder(s) as of the date of the Proposal Request,
and a representation that the Proposing Shareholder(s) intends to appear in person or by proxy at the meeting; (iii) the matter requested to be included on the agenda of a General Meeting, all information related to such matter, the reason
that such matter is proposed to be brought before the General Meeting, the complete text of the resolution that the Proposing Shareholder proposes to be voted upon at the General Meeting and, if the Proposing Shareholder wishes to have a
position statement in support of the Proposal Request, a copy of such position statement that complies with the requirement of any applicable law (if any), (iv) a description of all arrangements or understandings between the Proposing
Shareholders and any other Person(s) (naming such Person or Persons) in connection with the matter that is requested to be included on the agenda and a declaration signed by all Proposing Shareholder(s) of whether any of them has a personal
interest in the matter and, if so, a description in reasonable detail of such personal interest; (v) a description of all Derivative Transactions (as defined below) by each Proposing Shareholder(s) during the previous twelve (12) month
period, including the date of the transactions and the class, series and number of securities involved in, and the material economic terms of, such Derivative Transactions; and (vi) a declaration that all of the information that is required
under the Companies Law and any other applicable law and stock exchange rules and regulations to be provided to the Company in connection with such matter, if any, has been provided to the Company. The Board of Directors, may, in its
discretion, to the extent it deems necessary, request that the Proposing Shareholder(s) provide additional information necessary so as to include a matter in the agenda of a General Meeting, as the Board of Directors may reasonably require.
|
2022
|
2023
|
|||||||
Audit Fees
|
$
|
872
|
$
|
1,010
|
||||
Audit‑Related Fees
|
33
|
-
|
||||||
Tax Fees
|
749
|
262
|
||||||
All Other Fees
|
57
|
45
|
||||||
Total
|
$
|
1,711
|
$
|
1,317
|
|
By order of the Board of Directors: |
|
|
|
Donna Rahav, |
|
Chief Legal Officer
|
|
• |
ARR is defined as the annualized value of active SaaS, self-hosted subscriptions and their associated maintenance and support services, and maintenance contracts related to the perpetual licenses in effect at the end of the reported period.
|
|
• |
Subscription portion of ARR is defined as the annualized value of active SaaS and self-hosted subscription contracts in effect at the end of the reported period. The subscription portion of ARR excludes maintenance contracts related to
perpetual licenses.
|
Twelve Months Ended
|
||||||||
December 31,
|
||||||||
2022
|
2023
|
|||||||
Operating loss
|
$
|
(152,450
|
)
|
$
|
(116,472
|
)
|
||
Plus:
|
||||||||
Share-based compensation (1)
|
120,821
|
140,101
|
||||||
Amortization of share-based compensation capitalized in software development costs (3)
|
346
|
393
|
||||||
Amortization of intangible assets (2)
|
6,655
|
7,364
|
||||||
Acquisition related expenses
|
2,244
|
-
|
||||||
Impairment of capitalized software development costs (3)
|
-
|
2,067
|
||||||
Non-GAAP operating income (loss)
|
$
|
(22,384
|
)
|
$
|
33,453
|
Twelve Months Ended
|
||||||||
December 31,
|
||||||||
2022
|
2023
|
|||||||
Cost of revenues - Subscription
|
$
|
2,264
|
$
|
4,178
|
||||
Cost of revenues - Perpetual license
|
143
|
45
|
||||||
Cost of revenues - Maintenance and Professional services
|
12,653
|
13,389
|
||||||
Research and development
|
27,102
|
29,458
|
||||||
Sales and marketing
|
51,099
|
58,790
|
||||||
General and administrative
|
27,560
|
34,241
|
||||||
Total share-based compensation
|
$
|
120,821
|
$
|
140,101
|
Twelve Months Ended
|
||||||||
December 31,
|
||||||||
2022
|
2023
|
|||||||
Cost of revenues - Subscription
|
$
|
5,894
|
$
|
6,817
|
||||
Cost of revenues - Perpetual license
|
150
|
-
|
||||||
Sales and marketing
|
611
|
547
|
||||||
Total amortization of intangible assets
|
$
|
6,655
|
$
|
7,364
|
||||
(3) Classified as Cost of revenues - Subscription.
|
WHEREAS, |
Indemnitee is an Office Holder (“Nosse Misra”), as such term is defined in the Companies Law, 5759–1999, as amended (the “Companies
Law” and “Office Holder” respectively), of the Company, and, at the request of the Company, may serve in the capacity of an Office Holder of a company controlled by the Company;
|
WHEREAS, |
both the Company and Indemnitee recognize the increased risk of litigation and other claims being asserted against Office Holders of companies and that highly competent persons have become more reluctant to serve corporations as directors
and officers or in other capacities unless they are provided with adequate protection through insurance or adequate indemnification against inordinate risks of claims and actions against them arising out of their service to, and activities on
behalf of, companies;
|
WHEREAS, |
the Amended and Restated Articles of Association of the Company (the “Articles of Association”) authorize the Company to indemnify and advance expenses to its Office Holders and provide for insurance
and exculpation to its Office Holders, in each case, to the fullest extent permitted by applicable law;
|
WHEREAS, |
the Company has determined that (i) the increased difficulty in attracting and retaining competent persons is detrimental to the best interests of the Company’s shareholders and that the Company should act to assure such persons that there
will be increased certainty of such protection in the future, and (ii) it is reasonable, prudent and necessary for the Company contractually to obligate itself to indemnify, and to advance expenses on behalf of, such persons to the fullest
extent permitted by applicable law, so that they will serve or continue to serve the Company directly or, at the Company’s request, through another entity controlled by the Company, free from undue concern that they will not be so indemnified;
and
|
WHEREAS, |
in recognition of Indemnitee’s need for substantial protection against personal liability in order to assure Indemnitee’s continued service to the Company directly or, at the Company’s request, through another entity controlled by the
Company, in an effective manner and, in part, in order to provide Indemnitee with specific contractual assurance that the indemnification, insurance and exculpation afforded by the Articles of Association will be available to Indemnitee, the
Company wishes to undertake in this Agreement for the indemnification of and the advancing of expenses to Indemnitee to the fullest extent permitted by applicable law and as set forth in this Agreement and provide for insurance and exculpation
of Indemnitee as set forth in this Agreement.
|
1. |
INDEMNIFICATION AND INSURANCE.
|
|
1.1 |
The Company hereby undertakes to indemnify Indemnitee to the fullest extent permitted by applicable law for any liability and expense specified in Sections 1.1 through 1.1.4 below, imposed on Indemnitee due to or
in connection with an act performed by such Indemnitee, either prior to or after the date hereof, in Indemnitee’s capacity as an Office Holder, including, without limitation, as a director, officer, employee, agent or fiduciary of the Company,
any subsidiary thereof or any other corporation, collaboration, partnership, joint venture, trust or other enterprise, in which Indemnitee serves at any time at the request of the Company (the “Corporate
Capacity”). The term “act performed in Indemnitee’s capacity as an Office Holder” shall include, without limitation, any act, omission or failure to act and any other circumstances relating to or arising from Indemnitee’s service in a
Corporate Capacity. The following shall be hereinafter referred to as “Indemnifiable Events”:
|
|
1.1.1. |
Financial liability imposed on Indemnitee in favor of any person pursuant to a judgment, including a judgment rendered in the context of a settlement or an arbitrator’s award approved by a court. For purposes of
Section 1 of this Agreement, the term “person” shall include, without limitation, a natural person, firm, partnership, joint venture, trust, company, corporation, limited liability entity, unincorporated
organization, estate, government, municipality, or any political, governmental, regulatory or similar agency or body;
|
|
1.1.2. |
Reasonable Expenses (as defined below) expended by Indemnitee as a result of an investigation or any proceeding instituted against the Indemnitee by an authority that is authorized to conduct such investigation
or proceeding, and that was concluded without filing an indictment against the Indemnitee and without imposing on the Indemnitee a financial liability in lieu of a criminal proceeding, or that was concluded without filing an indictment against
the Indemnitee but imposing a financial liability in lieu of a criminal proceeding in an offence that does not require proof of mens rea, or in connection with a financial sanction. In this section
“conclusion of a proceeding without filing an indictment in a matter in which a criminal investigation has been instigated” and “financial liability in lieu of a criminal proceeding” shall have the meaning assigned to such terms under the
Companies Law, and the term “financial sanction” shall mean such term as referred to in Section 260(a)(1a) of the Companies Law;
|
|
1.1.3. |
Reasonable Expenses expended by or imposed on Indemnitee by a court, in a proceeding instituted against Indemnitee by the Company or on its behalf or by another person, or in a criminal charge from which
Indemnitee was acquitted or in which Indemnitee convicted of an offence that does not require proof of mens rea; and
|
|
1.1.4. |
Any other event, occurrence, matter or circumstances under any law with respect to which the Company may, or will be able to, indemnify an Office Holder (including, without limitation, in accordance with Section
56h(b)(1) of the Israeli Securities Law 5728-1968 (the “Israeli Securities Law”), if applicable, and Section 50P(b)(2) of the Israeli Economic Competition Law,
5758-1988 (the “Economic Competition Law”)).
|
|
1.2 |
Notwithstanding anything herein to the contrary, the Company’s undertaking to indemnify the Indemnitee under Section 1.1 shall only be with respect to events described in Exhibit
A hereto (without limitation of the Company's ability to indemnity retroactively, at its discretion and subject to applicable law). The Board of Directors of the Company (the “Board”) has
determined that the categories of events listed in Exhibit A are foreseeable in light of the operations of the Company. The maximum amount of indemnification payable by the Company to the
Indemnitee under Section 1.1 and other indemnitees under similar indemnification agreements with the Company (the “Indemnifiable Persons”) shall be as set forth in Exhibit
A hereto (the “Limit Amount”) for each five year period commencing on [________], and for every subsequent five year period thereafter, and shall apply to all Indemnifiable Persons, in the
aggregate. If the Limit Amount is insufficient to cover all the indemnity amounts payable with respect to all Indemnifiable Persons during the relevant five year period, then such amount shall be allocated to such Indemnifiable Persons pro rata
according to the percentage of their culpability, as finally determined by a court in the relevant claim, or, absent such determination or in the event such persons are parties to different claims, based on an equal pro rata allocation among
such Indemnifiable Persons. The Limit Amount payable by the Company as described in Exhibit A is deemed by the Company to be reasonable in light of the circumstances. The indemnification provided under Section 1.1 herein shall not be subject to
the limitations imposed by this Section 1.2 and Exhibit A if and to the extent such limits are not or are no longer required by the Companies Law.
|
|
1.3 |
If so requested by Indemnitee in writing, and subject to the Company’s repayment and reimbursements rights set forth in Sections 3 and 5 below, the Company shall pay amounts to cover Indemnitee’s Expenses with
respect to which Indemnitee is entitled to be indemnified under Section 1 above, as and when incurred. The payments of such amounts shall be made by the Company directly to the Indemnitee’s legal and other advisors, as soon as practicable, but
in any event no later than fifteen (15) days after written demand by such Indemnitee therefor to the Company, and any such payment shall be deemed to constitute indemnification hereunder. As part of the aforementioned undertaking, the Company
will make available to Indemnitee any security or guarantee that Indemnitee may be required to post in accordance with an interim decision given by a court, governmental or administrative body, or an arbitrator, including for the purpose of
substituting liens imposed on Indemnitee’s assets.
|
|
1.4 |
The Company’s obligation to indemnify Indemnitee and advance Expenses in accordance with this Agreement shall be for such period (the “Indemnification Period”) as
Indemnitee shall be subject to any actual, possible or threatened claim, action, suit, demand or proceeding or any inquiry or investigation, whether civil, criminal or investigative, arising out of the Indemnitee’s service in the Corporate
Capacity as described in Section 1 above, whether or not Indemnitee is still serving in such position.
|
|
1.5 |
The Company undertakes that, subject to the mandatory limitations under applicable law, as long as it may be obligated to provide indemnification and advance Expenses under this Agreement, the Company will
purchase and maintain in effect directors and officers liability insurance, which will include coverage for the benefit of the Indemnitee, providing coverage in amounts as reasonably determined by the Board; provided that, the Company shall
have no obligation to obtain or maintain directors and officers insurance if the Company determines in good faith that such insurance is not reasonably available, or the premium for such insurance is disproportionate to the limits of liability
provided, or the coverage provided by such insurance is limited by exclusions that result in insufficient coverage. The Company hereby undertakes to notify the Indemnitee 30 days prior to the expiration or termination of the directors and
officers liability insurance.
|
|
1.6 |
The Company undertakes to give prompt written notice of the commencement of any claim hereunder to the insurers in accordance with the procedures set forth in the appliable insurance policy or policies. The
Company shall thereafter diligently take all actions reasonably necessary under the circumstances to cause such insurers to indemnify and/or pay, on behalf of Indemnitee, all amounts payable as a result of such action, suit, proceeding, inquiry
or official investigation in accordance with the terms of such policy or policies. The above shall not derogate from Company’s authority to freely negotiate or reach any compromise with the insurer which is reasonable at the Company’s sole
discretion provided that the Company shall act in good faith and in a diligent manner.
|
2. |
SPECIFIC LIMITATIONS ON INDEMNIFICATION.
|
3. |
REPAYMENT OF EXPENSES.
|
|
3.1 |
In the event that the Company provides or is required to provide indemnification with respect to Expenses hereunder and at any time thereafter the Company determines, based on advice from its legal counsel, that
the Indemnitee was not entitled to such payments, the amounts so indemnified by the Company will be promptly repaid by Indemnitee, unless the Indemnitee disputes the Company’s determination, in which case the Indemnitee’s obligation to repay to
the Company shall be postponed until such dispute is resolved.
|
|
3.2 |
Indemnitee’s obligation to repay the Company for any Expenses or other sums paid hereunder shall be deemed as a loan given to Indemnitee by the Company subject to the minimum interest rate prescribed by Section
3(9) of the Income Tax Ordinance [New Version], 1961, or any other legislation replacing it, which is not considered a taxable benefit.
|
4. |
SUBROGATION.
|
5. |
REIMBURSEMENT.
|
|
5.1 |
Notwithstanding any other provision of this Agreement, to the extent that Indemnitee is a witness or is made (or asked to) respond to discovery requests in any proceeding involving the Company, any subsidiary
thereof, any another person in which Indemnitee serves at any time at the request of the Company, its officers or directors, in their Corporate Capacities, to which Indemnitee is not a party, Indemnitee shall be indemnified against all expenses
paid or incurred by Indemnitee in connection therewith and in the manner set forth in this Agreement.
|
|
5.2 |
The Company shall not be liable under this Agreement to make any payment in connection with any Indemnifiable Event to the extent Indemnitee has otherwise actually received payment under any insurance policy or
otherwise (without any obligation of Indemnitee to repay any such amount) of the amounts otherwise indemnifiable hereunder. Any amounts paid to Indemnitee under such insurance policy or otherwise after the Company has indemnified Indemnitee for
such liability or Expense shall be repaid to the Company promptly upon receipt by Indemnitee, in accordance with the terms set forth in Section 3.2.
|
6. |
EFFECTIVENESS.
|
7. |
NOTIFICATION AND DEFENSE OF CLAIM.
|
|
7.1 |
The Company will be entitled to participate therein at its own expense.
|
|
7.2 |
Except as otherwise provided below, the Company, alone or jointly with any other indemnifying party similarly notified, will be entitled to assume the defense thereof, with counsel selected by the Company.
Indemnitee shall have the right to employ his or her own counsel in such action, suit or proceeding, but the fees and expenses of such counsel incurred after notice from the Company of its assumption of the defense thereof shall be at the
expense of Indemnitee, unless: (i) the employment of counsel by Indemnitee has been authorized in writing by the Company; (ii) the Company, in good faith, reasonably concluded that there may be a conflict of interest between the Company and
Indemnitee in the conduct of the defense of such action; or (iii) the Company has not in fact employed counsel to assume the defense of such action within reasonable time, in which cases the reasonable fees and expenses of Indemnitee’s counsel
shall be at the expense of the Company. The Company shall not be entitled to assume the defense of any action, suit or proceeding brought by or on behalf of the Company or as to which Indemnitee
and the Company shall have reached the conclusion specified in (ii) above.
|
|
7.3 |
The Company shall not be liable to indemnify Indemnitee under this Agreement for any amounts or expenses paid in connection with a settlement of any action, claim or otherwise, effected without the Company’s
prior written consent.
|
|
7.4 |
The Company shall have the right to conduct the defense as it sees fit in its sole discretion (provided that the Company shall conduct the defense in good faith and in a diligent manner), including the right to
settle or compromise any claim or to consent to the entry of any judgment against Indemnitee without the consent of the Indemnitee, provided that, the amount of such settlement, compromise or judgment does not exceed the Limit Amount (if
applicable) and is fully indemnifiable pursuant to this Agreement (subject to Section 1.1.2 of this Agreement) and/or applicable law, and any such settlement, compromise or judgment does not impose any penalty or limitation on Indemnitee
without the Indemnitee’s prior written consent. The Indemnitee’s consent shall not be required if the settlement includes a complete release of Indemnitee, does not contain any admission of wrong-doing by Indemnitee, and includes monetary
sanctions only as provided above. In the case of criminal proceedings the Company and/or its legal counsel will not have the right to plead guilty or agree to a plea-bargain in the Indemnitee’s name without the Indemnitee’s prior written
consent. Neither the Company nor Indemnitee will unreasonably withhold or delay their consent to any proposed settlement.
|
|
7.5 |
Indemnitee shall fully cooperate with the Company and shall give the Company all information and access to documents, files and to his or her advisors and representatives as shall be within Indemnitee’s power, in
every reasonable way as may be required by the Company with respect to any claim which is the subject matter of this Agreement and in the defense of other claims asserted against the Company (other than claims asserted by Indemnitee), provided
that the Company shall cover all expenses, costs and fees incidental thereto such that the Indemnitee will not be required to pay or bear such expenses, costs and fees.
|
|
7.6 |
If the Company fails to comply with any of its material obligations under this Agreement or in the event that the Company or any other person takes any action to declare this Agreement void or unenforceable, or
institutes any action, suit or proceeding to deny or to recover from Indemnitee the benefits intended to be provided to Indemnitee hereunder, except with respect to such actions, suits or proceedings brought by the Company that are resolved in
favor of the Company, Indemnitee shall have the right to retain counsel of Indemnitee’s choice, and reasonably acceptable to the Company and at the expense of the Company, to represent Indemnitee in connection with any such matter, to the
extent that such matter is within the provisions of Section 1 hereof.
|
8. |
EXCULPATION.
|
9. |
NON-EXCLUSIVITY.
|
10. |
PARTIAL INDEMNIFICATION.
|
11. |
BINDING EFFECT.
|
12. |
SEVERABILITY.
|
13. |
NOTICE.
|
14. |
GOVERNING LAW; JURISDICTION.
|
15. |
ENTIRE AGREEMENT.
|
16. |
ADVERSE PRESUMPTION.
|
17. |
NO MODIFICATION AND NO WAIVER.
|
18. |
ASSIGNMENTS; NO THIRD PARTY RIGHTS
|
19. |
SUCCESSORS.
|
20. |
INTERPRETATION; DEFINITIONS.
|
21. |
COUNTERPARTS
|
CyberArk Software Ltd.
|
By:
|
|
|
|
|
|
Name and title:
|
|
|
Indemnitee
|
Name:
|
|
|
|
|
|
Signature:
|
|
|
CATEGORY OF INDEMNIFIABLE EVENT
|
1.
|
Matters, events, occurrences or circumstances in connection or associated with employment relationships with employees or consultants or any employee union or similar or comparable
organization.
|
2.
|
Matters, events, occurrences or circumstances in connection or associated with business relations of any kind between the Company and its employees, independent contractors, customers,
suppliers, partners, distributors, agents, resellers, representatives, licensors, licensees, service providers and other business associates.
|
3.
|
Negotiations, execution, delivery and performance of agreements of any kind or nature and any decisions or deliberations relating to actions or omissions relating to the foregoing; any acts,
omissions or circumstances that do or may constitute or are alleged to constitute anti-competitive acts, acts of commercial wrongdoing, or failure to meet any standard of conduct which is or may be applicable to such acts, omissions or
circumstances.
|
4.
|
Approval of and recommendation or information provided to shareholders with respect to any and all corporate actions, including the approval of the acts of the Company’s management, their
guidance and their supervision, matters relating to the approval of transactions with Office Holders (including, without limitation, all compensation related matters) or shareholders, including controlling persons and claims and allegations of
failure to exercise business judgment, reasonable level of proficiency, expertise, care or any other applicable standard, with respect to the foregoing or otherwise with respect to the Company’s business, strategy, operations and prospective
outlook, and any discussions, deliberations, reviews or other preparatory or preliminary phases relating to any of the foregoing.
|
5.
|
Violation, infringement, misappropriation, dilution and other misuse of copyrights, patents, designs, trade secrets, confidential information, proprietary information and any intellectual
property rights, acts in connection with the registration, assertion or protection of rights to intellectual property and the defense of claims related to intellectual property, breach of confidentiality obligations, acts in regard of invasion
of privacy or any violation of privacy or privacy related right or regulation, including with respect to databases or handling, collection or use of private information, acts in connection with slander and defamation, and claims in connection
with publishing or providing any information, including any filings with any governmental authorities, whether or not required under any applicable laws.
|
6.
|
Violations of or failure to comply with securities laws, and any regulations or other rules promulgated thereunder, of any jurisdiction, including without limitation, claims under the U.S.
Securities Act of 1933 or the U.S. Exchange Act of 1934 or under the Israeli Securities Law, fraudulent disclosure claims, failure to comply with any securities authority or any stock exchange disclosure or other rules and any other claims
relating to relationships with investors, debt holders, shareholders, optionholders, holders of any other equity or debt instrument of the Company, and otherwise with the investment community (including without limitation any such claims
relating to a merger, acquisition, change in control transaction, issuance of securities, restructuring, spin out, spin off, divestiture, recapitalization or any other transaction relating to the corporate structure or organization of the
Company); claims relating to or arising out of financing arrangements, any breach of financial covenants or other obligations towards investors, lenders or debt holders, class actions, violations of laws requiring the Company to obtain
regulatory and governmental licenses, permits and authorizations in any jurisdiction, including in connection with disclosure, offering or other transaction related documents; actions taken in connection with the issuance, purchase, holding or
disposition of any type of securities of Company, including, without limitation, the grant of options, warrants or other rights to purchase any of the same or any offering of the Company’s securities (whether on behalf of the Company or on
behalf of any holders of securities of the Company) to private investors, underwriters, resellers or to the public, and listing of such securities, or the offer by the Company to purchase securities from the public or from private investors or
other holders, and any undertakings, representations, warranties and other obligations related to any of the foregoing or to the Company’s status as a public company or as an issuer of securities.
|
7.
|
Liabilities arising in connection with any products or services developed, distributed, rendered, sold, provided, licensed or marketed by the Company or any Affiliate thereof, and any actions
or omissions in connection with the distribution, provision, sale, marketing, license or use of such products or services, including without limitation in connection with professional liability and product liability claims or regulatory or
reputational matters.
|
8.
|
The offering of securities by the Company (whether on behalf of itself or on behalf of any holder of securities and any other person) to the public and/or to offerees or the offer by the
Company to purchase securities from the public and/or from private investors or other holders pursuant to a prospectus, offering documents, agreements, notices, reports, tenders and/or other processes.
|
9.
|
Events, facts or circumstances in connection with change in ownership or in the structure of the Company, its reorganization, dissolution, winding up, any other arrangements concerning
creditors rights, merger, change in control, issuances of securities, restructuring, spin out, spin off, divestiture, recapitalization or any other transaction relating to the corporate structure or organization of the Company, and the approval
of failure to approve of any corporate actions and any matters relating to corporate governance, capital structure, Articles of Association or other charter or governance documents, appointment or dismissal of Office Holders or compensation
thereof and appointment or dismissal of auditors, internal auditor or any other person performing any services for the Company.
|
10.
|
Any claim or demand made in connection with any transaction not in the ordinary course of business of the Company, as well as the sale, lease, purchase or acquisition of, or the receipt or
grant of any rights with respect to, any assets or business.
|
11.
|
Any claim or demand made by any third party suffering any personal injury and/or bodily injury or damage to business or personal property or any other type of damage through any act or omission
attributed to the Company, or its employees, agents or other persons acting or allegedly acting on its behalf, including, without limitation, failure to make proper safety arrangements for the Company or its employees and liabilities arising
from any accidental or continuous damage or harm to the Company’s employees, its contractors, its guests and visitors or any other third party as a result of an accidental or continuous event, or employment conditions, permanent or temporary,
in the Company’s offices.
|
12.
|
Any claim or demand made directly or indirectly in connection with complete or partial failure, by the Company or its directors, officers, employees or contractors, to pay, report, keep
applicable records or otherwise, of any local or foreign federal, state, county, municipal or city taxes or other taxes or compulsory payments of any nature whatsoever, including, without limitation, income, sales, use, transfer, excise, value
added, registration, severance, stamp, occupation, customs, duties, real property, personal property, capital stock, social security, unemployment, disability, payroll or employee withholding or other withholding, including any interest,
penalty or addition thereto, whether disputed or not.
|
13.
|
Any administrative, regulatory, judicial or civil actions orders,decrees, suits, demands, demand letters, directives, claims, liens, investigations, proceedings or notices of noncompliance or
violation by any governmental entity or other person alleging potential responsibility or liability (including potential responsibility or liability for costs of enforcement investigation, cleanup, governmental response, removal or remediation,
for natural resources damages, property damage, personal injuries or penalties or for contribution, indemnification, cost recovery, compensation or injunctive relief) arising out of, based on or related to (a) the presence of, release, spill,
emission, leaning, dumping, pouring, deposit, disposal, discharge, leaching or migration into the environment (each a “Release”) or threatened Release of, or exposure to, any hazardous, toxic, explosive
or radioactive substances, wastes or other pollutants, including petroleum or petroleum distillates, asbestos or asbestos-containing material, polychlorinated biphenyls (“PCBs”) or PCB-containing
materials or equipment, radon gas, infectious or medical wastes and all other substances or wastes of any nature regulated pursuant to any environmental law, at any location, whether or not owned, operated, leased or managed by the Company or any of its subsidiaries, or (b) circumstances forming the basis of any violation of any environmental law or environmental permit, license, registration or other authorization required
under applicable environmental law.
|
14.
|
Any administrative, regulatory or judicial actions, orders, decrees, suits, demands, demand letters, directives, claims, liens, investigations, proceedings or notices of noncompliance or
violation by any governmental or regulatory entity or authority or any other person alleging the failure to comply with any statute, law, ordinance, rule, regulation, order or decree of any governmental entity applicable to the Company or any
of its businesses, assets or operations, or the terms and conditions of any operating certificate or licensing agreement.
|
15.
|
Participation and/or non-participation at the Company’s Board meetings, expression of opinion or view and/or voting and/or abstention from voting at the Company’s Board meetings, including, in
each case, any committee thereof, as well as expression of opinion publicly in connection with the service as an Office Holder.
|
16.
|
Review and approval of the Company’s financial statements and any specific items or matters within, including any action, consent or approval related to or arising from the foregoing,
including, without limitations, engagement of or execution of certificates for the benefit of third parties related to the financial statements.
|
17.
|
Violation of laws, rules or regulations requiring the Company to obtain regulatory and governmental licenses, permits and authorizations (including without limitation relating to export,
import, encryption, antitrust or competition authorities) or laws related to any governmental grants in any jurisdiction.
|
18.
|
Resolutions and/or actions relating to investments in the Company and/or its subsidiaries and/or affiliated companies and/or investment in corporate or other entities and/or investments in
other traded or non-traded securities and/or any other form of investment.
|
19.
|
Liabilities arising out of advertising, including misrepresentations regarding the Company’s products or services and unlawful distribution of emails.
|
20.
|
Management of the Company’s bank accounts, including money management, foreign currency deposits, securities, loans and credit facilities, credit cards, bank guarantees, letters of credit,
consultation agreements concerning investments including with portfolio managers, hedging transactions, options, futures, and the like.
|
21.
|
All actions, consents and approvals, including any prior discussions, reviews and deliberations, relating to a distribution of dividends, in cash or otherwise, or to any other “distribution” as
such term is defined under the Companies Law.
|
22.
|
Any administrative, regulatory, judicial, civil or criminal, actions orders, decrees, suits, demands, demand letters, directives, claims, liens, investigations, proceedings or notices of
noncompliance, violation or breaches alleging potential responsibility, liability, loss or damage (including potential responsibility or liability for costs of enforcement, investigation, cleanup, governmental response, removal or remediation,
property damage or penalties, or for contribution, indemnification, cost recovery, compensation or injunctive relief), whether alleged or claimed by customers, partners, vendors, consumers, regulators, shareholders or others, arising out of,
based on or related to: (a) cyber security, cyber attacks, data loss or breaches, unauthorized access to information, data, or databases (including but not limited to any personally identifiable information or private health information) and
use or disclosure of information contained therein, not preventing or detecting the breach or failing to otherwise disclose or respond to the breach; (b) circumstances forming the basis of any violation of any law, permit, license, registration
or other authorization required under applicable law governing data security, data protection, network security, information systems, privacy or any cyber environment (including, users, networks, devices, software, processes, information
systems, databases, information in storage or transit, applications, services, and systems that can be connected directly or indirectly to networks); (c) failure to implement a process, tool, reporting system or control, or failure to monitor
or oversee the operation of such a system or process; (d) data destruction, extortion, theft, hacking, and denial of service attacks; losses or liabilities to others caused by errors and omissions, failure to safeguard data or defamation; or
(e) security-audit, post-incident public relations and investigative expenses, criminal reward funds, data breach/privacy crisis management (including, management of an incident, investigation, remediation, data subject notification, call
management, credit checking for data subjects, legal costs, court attendance and regulatory fines), extortion liability (including, losses due to a threat of extortion, professional fees related to dealing with the extortion), or network
security liability (including, losses as a result of denial of access, costs related to data on third-parties and costs related to the theft of data on third-party systems).
|
The Limit Amount for all Indemnifiable Persons during each relevant period referred to in Section 1.2 of the Indemnification Agreement for all events described in this Exhibit A (in Sections
1-22 (inclusive) above), shall be the greater of:
(a) twenty-five percent (25%) of the Company’s total shareholders’ equity according to the Company’s most recent financial statements as of the time of the actual payment
of indemnification;
(b) US$ 200 million;
(c) ten percent (10%) of the Company Total Market Cap (which shall mean the average closing price of the Company’s ordinary shares over the 30 trading days prior to the
actual payment of indemnification multiplied by the total number of issued and outstanding shares of the Company as of the date of actual payment); and
(d) in connection with or arising out of a public offering of the Company’s securities, the aggregate amount of proceeds from the sale by the Company and/or any
shareholder of Company’s securities in such offering.
|
* |
Any reference in this Exhibit A to the Company shall include the Company and any entity in which the Indemnitee serves in a Corporate Capacity.
|
![]() |
![]() |
CYBERARK SOFTWARE LTD.
C/O PROXY SERVICES
P.O. BOX 9142
FARMINGDALE, NY 11735
|
VOTE BY INTERNET - www.proxyvote.com or scan the QR Barcode above
Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 a.m. Eastern Time the
day before the cut-off date or meeting date. Have your proxy card in hand when you access the website and follow the instructions to obtain your records and to create an electronic voting instruction form.
ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS
If you would like to reduce the costs incurred by our company in mailing proxy materials, you can consent to receiving all future
proxy statements, proxy cards and annual reports electronically via e-mail or the Internet. To sign up for electronic delivery, please follow the instructions above to vote using the Internet and, when prompted, indicate that
you agree to receive or access proxy materials electronically in future years.
VOTE BY PHONE - 1-800-690-6903
Use any touch-tone telephone to transmit your voting instructions up until 11:59 a.m. Eastern Time the day before the cut-off date or
meeting date. Have your proxy card in hand when you call and then follow the instructions.
VOTE BY MAIL
Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o
Broadridge, 51 Mercedes Way, Edgewood, NY 11717.
|
D87164-P76795
|
KEEP THIS PORTION FOR YOUR RECORDS
|
|
DETACH AND RETURN THIS PORTION ONLY
|
CYBERARK SOFTWARE LTD.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
1. |
(1)
|
To re-elect each of Matthew Cohen and François Auque, each for a term of approximately three years as a Class I director of CyberArk Software Ltd. (the “Company”), until the Company’s annual general
meeting of shareholders to be held in 2027 and until their respective successor is duly elected and qualified; and
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
(2) | To elect Mary Yang for a term of approximately three years as a Class I director of the Company, until the Company’s annual general meeting of shareholders to be held in 2027 and until her successor is duly elected and qualified; |
|
For |
Against
|
Abstain
|
|
|
|
For |
Against
|
Abstain
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1(1)a. Matthew Cohen |
|
|
|
☐ | ☐ | ☐ |
|
3. |
To approve amendments to the form of indemnification agreement for certain office holders of the Company;
|
☐
|
☐
|
☐
|
||||
|
1(1)b. François Auque
|
☐ | ☐ |
☐ |
|
|
|
|
|||||||||||
|
|
|
1(2). Mary Yang
|
|
|
|
|
☐ | ☐ | ☐ |
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
||||||||||
|
2. |
|
To approve, in accordance with the requirements of the Israeli Companies Law, 5759-1999, a grant of performance share units and restricted share units for 2024 to the Company’s Executive Chairman of the Board, Ehud (Udi) Mokady; |
|
☐ | ☐ | ☐ |
|
4. | To approve certain amendments to the articles of association of the Company; and | ☐ | ☐ |
☐
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
5. |
To approve the re-appointment of Kost Forer Gabbay & Kasierer, registered public accounting firm, a member firm of Ernst & Young Global, as the Company’s independent registered public accounting
firm for the year ending December 31, 2024, and until the Company’s 2025 annual general meeting of shareholders, and to authorize the Board to fix such accounting firm’s annual compensation.
|
☐ | ☐ | ☐ | |||||||||
Please sign your name exactly as it appears hereon. When signing as attorney, executor, administrator, trustee or guardian, please add your title as such. When signing as joint tenants, all parties in the
joint tenancy must sign. If a signer is a corporation, please sign in full corporate name by duly authorized officer.
|
|||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Signature [PLEASE SIGN WITHIN BOX]
|
Date
|
Signature (Joint Owners)
|
Date |
D87165-P76795
|